Latest filingSep 11, 2026Most recent Form 4
EW
Edwards Lifesciences Corp
NYSEHealthcareOrthopedic, Prosthetic & Surgical Appliances & Supplies
Insider activity for last month from 08/12 to 09/12. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$334M6 sells
Net open-market-$334M5 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period11transactions
- S · Open-market sells · dominant6 · 55%
- M · Option exercise4 · 36%
- F · Tax withholding1 · 9%
Activity by reported role
A joint filing can contribute to multiple roles26transactions
- CVP · dominant10 · 38%
- IHFM5 · 19%
- TMTT5 · 19%
- TAVR3 · 12%
- CTRL1 · 4%
- JAPAC1 · 4%
- SVP1 · 4%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (4)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeChopra DaveenCommon Stock · Direct
43,926Sep 11, 2026
Lippis Daniel J.Common Stock · Direct
40,652.9103Sep 11, 2026
Markowitz WayneCommon Stock · Direct
20,293.5581Aug 26, 2026
Chopra DaveenEmployee Stock Option (Right to Acquire) · Direct
0Aug 26, 2026
Bruls AnnetteCommon Stock · Direct
17,984Aug 28, 2026
Dahl Andrew M.Common Stock · Direct
14,868.41Aug 31, 2026
Lippis Daniel J.Employee Stock Option (Right to Acquire) · Direct
3,714Sep 11, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 12 → Sep 12
LessMore
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
EW transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
No transactions match your filtersOnce the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range. | ||||||||||
Edwards Lifesciences Corp Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Edwards Lifesciences Corp?
Chopra Daveen, Lippis Daniel J., Dahl Andrew M., Bruls Annette, Markowitz Wayne.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Lippis Daniel J. reported a sale on Sep 11, 2026 valued at $5.41M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $3,349,465.95. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.